Literature DB >> 3902143

Antiviral therapy in hepatitis B infection.

H C Thomas, L J Scully.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902143     DOI: 10.1093/oxfordjournals.bmb.a072079

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  11 in total

1.  Effects of interferon-alpha therapy on serum and liver HBV DNA in patients with chronic hepatitis B.

Authors:  S V Feinman; B Berris; R Sooknanan; B Fernandes; S Bojarski
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

2.  Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

Authors:  M G Brook; J A McDonald; P Karayiannis; L Caruso; G Forster; J R Harris; H C Thomas
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

3.  Liver disease in general practice.

Authors:  L Scully
Journal:  Can Fam Physician       Date:  1988-03       Impact factor: 3.275

Review 4.  Persistent herpes simplex virus infection and mechanisms of virus drug resistance.

Authors:  H J Field
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

5.  Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients.

Authors:  C Ferri; A L Zignego; G Longombardo; M Monti; L La Civita; F Lombardini; F Greco; A Mazzoni; G Pasero; P Gentilini
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

6.  Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.

Authors:  S Takano; M Omata; O Yokosuka; F Imazeki; M Ohto
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

7.  Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.

Authors:  M G Anderson; T J Harrison; G Alexander; A J Zuckerman; I M Murray-Lyon
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

8.  Effect of recombinant interleukin 2 on hepatitis B e antigen positive chronic hepatitis.

Authors:  M Onji; H Kondoh; N Horiike; S Yamaguchi; Y Ogawa; I Kumon; Y Ohta
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

9.  The affinity of anti-HBc antibodies in acute and chronic hepatitis B infection.

Authors:  Y M Wen; S C Duan; C R Howard; A F Frew; M W Steward
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

10.  Effects of acyclovir and vidarabin 5'-monophosphate on anti-duck hepatitis B virus in an in vitro culture system.

Authors:  K Motegi
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.